51 related articles for article (PubMed ID: 10354693)
21. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of the enhaled glucocorticosteroid effect on non-specific and specific bronchial reactivity with particular reference to the late inflammatory phase in atopic asthma patients. I. The effect of a single dose of budesonide R on specific and non-specific bronchial reactivity].
Chyrek-Borowska S; Siergiejko Z; Rogalewska A; Zietkowski Z
Pol Merkur Lekarski; 1998 May; 4(23):247-9. PubMed ID: 9825653
[TBL] [Abstract][Full Text] [Related]
23. Monitoring of serum eosinophil cationic protein (ECP) level and its clinical value in paediatric practice.
Zápalka M; Kopriva F; Szotkowská J
Acta Univ Palacki Olomuc Fac Med; 1998; 141():21-3. PubMed ID: 9684475
[TBL] [Abstract][Full Text] [Related]
24. Asthma, bronchial hyperreactivity and mediator release in children with birch pollinosis. ECP and EPX levels are not related to bronchial hyperreactivity.
Ferdousi HA; Dreborg S
Clin Exp Allergy; 1997 May; 27(5):530-9. PubMed ID: 9179427
[TBL] [Abstract][Full Text] [Related]
25. The use of serum eosinophil cationic protein (ECP) in the management of steroid therapy in chronic asthma.
Wever AM; Wever-Hess J; Hermans J
Clin Exp Allergy; 1997 May; 27(5):519-29. PubMed ID: 9179426
[TBL] [Abstract][Full Text] [Related]
26. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol.
Swystun VA; Gordon JR; Davis EB; Zhang X; Cockcroft DW
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):57-64. PubMed ID: 10887306
[TBL] [Abstract][Full Text] [Related]
27. Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma.
Wenzel SE; Lumry W; Manning M; Kalberg C; Cox F; Emmett A; Rickard K
Ann Allergy Asthma Immunol; 1998 Jun; 80(6):463-70. PubMed ID: 9647268
[TBL] [Abstract][Full Text] [Related]
28. Fluticasone and ibuprofen do not add to the effect of salmeterol on organic dust-induced airway inflammation and bronchial hyper-responsiveness.
Strandberg K; Ek A; Palmberg L; Larsson K
J Intern Med; 2008 Jul; 264(1):83-94. PubMed ID: 18298484
[TBL] [Abstract][Full Text] [Related]
29. Predictors of early- and late-phase reactions to bronchial allergen challenge.
Haugaard L; Iversen M; Dahl R
Allergy; 1997 Oct; 52(10):999-1004. PubMed ID: 9360751
[TBL] [Abstract][Full Text] [Related]
30. [Value of a specific bronchial provocation test in comparison with other methods in diagnosis of atopic bronchial asthma].
Siergiejko Z; Michalska I; Zietkowski Z; Chyrek-Borowska S
Pneumonol Alergol Pol; 1995; 63(3-4):170-5. PubMed ID: 7544185
[TBL] [Abstract][Full Text] [Related]
31. The effect of salmeterol and salbutamol on mediator release and skin responses in immediate and late phase allergic cutaneous reactions.
Petersen LJ; Skov PS
Inflamm Res; 1999 Oct; 48(10):527-32. PubMed ID: 10563469
[TBL] [Abstract][Full Text] [Related]
32. The effect of oral zindotrine (MDL-257), a bronchial smooth muscle relaxant, on histamine airways responsiveness in asymptomatic asthmatics.
Küng M; Bangs SE; Gordon EE; Barker KB; Diamond L
Ann Allergy; 1987 Sep; 59(3):201-6. PubMed ID: 3307547
[TBL] [Abstract][Full Text] [Related]
33. Criteria for the clinical evaluation of prophylactic agents in bronchial asthma.
Craps L
Int Arch Allergy Appl Immunol; 1981; 66 Suppl 1():272-8. PubMed ID: 7309262
[TBL] [Abstract][Full Text] [Related]
34. Effect of prior medication on intradermal test response in patients with respiratory allergies.
Agarwal MK; Gaur SN; Chaudhry S
J Asthma; 1988; 25(5):275-9. PubMed ID: 3182592
[TBL] [Abstract][Full Text] [Related]
35. Ryan's "Work and Effort": a reply.
JOHNSON HM
Psychol Bull; 1951 Jan; 48(1):77-8. PubMed ID: 14808487
[No Abstract] [Full Text] [Related]
36. Ryan's Medicare overhaul remains a talking point.
Demko P
Mod Healthc; 2015 Jan; 45(4):20-2. PubMed ID: 25671916
[No Abstract] [Full Text] [Related]
37. [The effect of salmeterol on specific and non-specific bronchial response in allergic asthma patients].
Siergiejko Z
Pneumonol Alergol Pol; 1998; 66(9-10):440-9. PubMed ID: 10354693
[TBL] [Abstract][Full Text] [Related]
38. [The effect of salmeterol on the number of hypodense eosinophils, eosinophilic cationic protein levels ECP in serum, bronchial hyperresponsiveness and lung function test in patients with bronchial asthma].
Chazan R; Grubek-Jaworska H; Hermanowicz-Salomon J; Droszcz W
Pol Merkur Lekarski; 1997 Oct; 3(16):180-2. PubMed ID: 9461726
[TBL] [Abstract][Full Text] [Related]
39. The effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X.
Pedersen B; Dahl R; Larsen BB; Venge P
Allergy; 1993 Jul; 48(5):377-82. PubMed ID: 8103646
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of the inhaled glucocorticosteroid effects on non specific bronchial reactivity with particular reference to the late inflammatory phase in atopic asthma patients. II. The effect of regular administration of budesonide R on specific and non-specific bronchial reactivity].
Siergiejko Z; Chyrek-Borowska S; Rogalewska A; Zietkowski Z
Pol Merkur Lekarski; 1998 May; 4(23):250-3. PubMed ID: 9825654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
